A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior-Reference-Cited by-同舟云学术

A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior

Published:2008-01 Issue:1 Volume:132 Page:125-136
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Beaulieu Jean-Martin,Marion Sébastien,Rodriguiz Ramona M.,Medvedev Ivan O.,Sotnikova Tatyana D.,Ghisi Valentina,Wetsel William C.,Lefkowitz Robert J.,Gainetdinov Raul R.,Caron Marc G.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference52 articles.

1. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor;Ahn;J. Biol. Chem.,2004

2. Mechanism of activation and function of protein kinase B;Alessi;Curr. Opin. Genet. Dev.,1998

3. A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation;Barak;J. Biol. Chem.,1997

4. Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs;Beaulieu;Int. J. Neuropsychopharmacol.,2007

5. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade;Beaulieu;Proc. Natl. Acad. Sci. USA,2004

Cited by 314 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary sucrose determines the regulatory activity of lithium on gene expression and lifespan in Drosophila melanogaster;Aging;2024-06-10

2. Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives;IBRO Neuroscience Reports;2024-06

3. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview;Pharmacological Reviews;2024-02-08

4. A statistical method for image-mediated association studies discovers genes and pathways associated with four brain disorders;The American Journal of Human Genetics;2024-01

5. New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases;Biochemical Pharmacology;2023-12